Cargando…

Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model

Current therapies for Parkinson's disease (PD), including L‐3,4‐dihydroxyphenylalanine (L‐DOPA), and clinical trials investigating dopaminergic cell transplants, have generated mixed results with the eventual induction of dyskinetic side effects. Although human umbilical cord blood (hUCB) stem/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jea‐Young, Tuazon, Julian P., Ehrhart, Jared, Sanberg, Paul R., Borlongan, Cesario V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653272/ https://www.ncbi.nlm.nih.gov/pubmed/31148353 http://dx.doi.org/10.1111/jcmm.14429

Ejemplares similares

A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson’s Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity
por: Lee, Jea-Young, et al.
Publicado: (2019)

Correction to: A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson’s Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity
por: Lee, Jea-Young, et al.
Publicado: (2022)

Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases
por: Ehrhart, Jared, et al.
Publicado: (2018)

Probing Gut Participation in Parkinson’s Disease Pathology and Treatment via Stem Cell Therapy
por: Lee, Jea-Young, et al.
Publicado: (2023)

Inflammatory gut as a pathologic and therapeutic target in Parkinson’s disease
por: Lee, Jea-Young, et al.
Publicado: (2022)

Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2018)

Umbilical cord blood immune cell profiles in relation to the infant gut microbiome
por: Moroishi, Yuka, et al.
Publicado: (2022)

A Hallmark Clinical Study of Cord Blood Therapy in Adults with Ischemic Stroke
por: Sanberg, Paul R., et al.
Publicado: (2019)

Getting the guts to expand stroke treatment: The potential for microbiome targeted therapies
por: Monsour, Molly, et al.
Publicado: (2022)

Human stem cells transplanted into the rat stroke brain migrate to the spleen via lymphatic and inflammation pathways
por: Xu, Kaya, et al.
Publicado: (2019)

Beneficial Effects of Transplanted Human Bone Marrow Endothelial Progenitors on Functional and Cellular Components of Blood-Spinal Cord Barrier in ALS Mice
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2021)

Mitochondrial activity of human umbilical cord mesenchymal stem cells
por: Cozene, Blaise M., et al.
Publicado: (2021)

Hernia of Umbilical Cord with Congenital Short Gut
por: Mirza, Bilal, et al.
Publicado: (2014)

Suppressed acoustic startle response in traumatic brain injury masks post-traumatic stress disorder hyper-responsivity
por: Liska, Grant M., et al.
Publicado: (2018)

Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
por: Toledo, Alma Rosa Lezama, et al.
Publicado: (2022)

Enhancing endogenous stem cells in the newborn via delayed umbilical cord clamping
por: Lawton, Christopher, et al.
Publicado: (2015)

Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
por: Romano, Stefano, et al.
Publicado: (2021)

Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
por: Gordon, Jonah, et al.
Publicado: (2022)

Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts
por: Yasuhara, T, et al.
Publicado: (2010)

Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2008)

Cytokine profiling of umbilical cord blood plasma
por: Au, Katrina K, et al.
Publicado: (2014)

Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
por: Chiang, Han-Lin, et al.
Publicado: (2019)

Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
por: Pavan, Sujith, et al.
Publicado: (2022)

Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
por: Salim, Safa, et al.
Publicado: (2022)

Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
por: Mehanna, Mohammad, et al.
Publicado: (2023)

The Gut Microbiome, Inflammation, and Salt-Sensitive Hypertension
por: Elijovich, Fernando, et al.
Publicado: (2020)

Diet and microbiome in the beginning of the sequence of gut inflammation
por: Ceballos, Daniel, et al.
Publicado: (2021)

Editorial: Nutrients, Gut Microbiome, and Intestinal Inflammation
por: Yang, Fang, et al.
Publicado: (2022)

The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy
por: Borlongan, Mia C., et al.
Publicado: (2020)

Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson’s Disease
por: Singh, Yogesh, et al.
Publicado: (2019)

Effect of Vancomycin on the Gut Microbiome and Plasma Concentrations of Gut-Derived Uremic Solutes
por: Nazzal, Lama, et al.
Publicado: (2021)

Combination Therapy of Human Umbilical Cord Blood Cells and Granulocyte Colony Stimulating Factor Reduces Histopathological and Motor Impairments in an Experimental Model of Chronic Traumatic Brain Injury
por: Acosta, Sandra A., et al.
Publicado: (2014)

Energy Metabolism Analysis of Three Different Mesenchymal Stem Cell Populations of Umbilical Cord Under Normal and Pathologic Conditions
por: Russo, Eleonora, et al.
Publicado: (2020)

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
por: Chen, Qian-Qian, et al.
Publicado: (2019)

Gut-Derived Sterile Inflammation and Parkinson's Disease
por: Shannon, Kathleen M.
Publicado: (2022)

(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease
por: Buford, Thomas W.
Publicado: (2017)

Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis
por: Liu, Airu, et al.
Publicado: (2023)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
por: Wallen, Zachary D., et al.
Publicado: (2021)

Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
por: Lubomski, Michal, et al.
Publicado: (2022)

Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection
por: Hey, Grace, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f33a2t60bed0o85nnfmf66orht